WHO R&D Blueprint COVID-19 Vaccines Working Group
The WHO R&D Blueprint COVID-19 Vaccines Working Group, also known as the Working Group on Target Product Profile for Vaccines Against COVID-19, is an advisory body of the World Health Organization's R&D Blueprint.
History
The working group was established in April 2020.1)
Membership
| Name | Position | Affiliation |
|---|---|---|
| Philip Krause | Chair | Food and Drug Administration (FDA) |
| Jon Abramson | Member | WHO Strategic Advisory Group on Immunization, Wake Forest University School of Medicine |
| Gangandeep Kang | Member | Wellcome Trust Research Laboratory (WTRL) |
| Patricia Garcia | Member | Cayetano Heredia University, University of Washington |
| Karianne Johansen | Member | Norwegian Institute of Public Health |
| Ira Longini | Member | Center for Statistics & Quantitative Infectious Diseases (CSQUID) |
| Aurelia Nguyen | Member | Gavi, the Vaccine Alliance |
| Yot Teerawattananon | Member | Thailand Research Fund (TRF) |
| Ana Maria Henao-Restrepo | Secretariat | World Health Organization |
| Pierre Gsell | Secretariat | World Health Organization |
| Ximena Riveros | Secretariat | World Health Organization |
External links
1)
WHO R&D Blueprint novel Coronavirus WHO Working Group - Target Product Profiles for COVID-19 Vaccines. (2020). World Health Organization. https://web.archive.org/web/20230312032002/https://cdn.who.int/media/docs/default-source/blue-print/tors-working-group-on-target-product-profiles-covid19.pdf?sfvrsn=f209d4b4_1&download=true